CN108186775B - 一种温和型伤口消毒液及其制备工艺 - Google Patents
一种温和型伤口消毒液及其制备工艺 Download PDFInfo
- Publication number
- CN108186775B CN108186775B CN201810123942.7A CN201810123942A CN108186775B CN 108186775 B CN108186775 B CN 108186775B CN 201810123942 A CN201810123942 A CN 201810123942A CN 108186775 B CN108186775 B CN 108186775B
- Authority
- CN
- China
- Prior art keywords
- parts
- filtering
- concentrating
- drying
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 96
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 244000306301 Caesalpinia sappan Species 0.000 claims abstract description 60
- 235000015162 Caesalpinia sappan Nutrition 0.000 claims abstract description 60
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 44
- 241000130781 Arnebia Species 0.000 claims abstract description 41
- 240000008067 Cucumis sativus Species 0.000 claims abstract description 40
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 39
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 39
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 39
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 39
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 39
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 39
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 39
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 39
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 39
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 39
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 37
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 37
- 240000004980 Rheum officinale Species 0.000 claims abstract description 27
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 27
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 24
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 23
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 23
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 17
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 13
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 6
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 5
- 238000001914 filtration Methods 0.000 claims description 126
- 239000000706 filtrate Substances 0.000 claims description 101
- 238000001035 drying Methods 0.000 claims description 90
- 239000000843 powder Substances 0.000 claims description 80
- 238000010992 reflux Methods 0.000 claims description 74
- 238000010438 heat treatment Methods 0.000 claims description 73
- 239000000243 solution Substances 0.000 claims description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 238000002156 mixing Methods 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 59
- 239000012153 distilled water Substances 0.000 claims description 55
- 241000245665 Taraxacum Species 0.000 claims description 44
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 43
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 241000213006 Angelica dahurica Species 0.000 claims description 34
- 238000000605 extraction Methods 0.000 claims description 32
- 241000565359 Fraxinus chinensis Species 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 25
- 241000218691 Cupressaceae Species 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 23
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 21
- 239000011345 viscous material Substances 0.000 claims description 20
- 241000130784 Arnebia euchroma Species 0.000 claims description 16
- 235000009849 Cucumis sativus Nutrition 0.000 claims description 16
- 238000000643 oven drying Methods 0.000 claims description 15
- 239000003208 petroleum Substances 0.000 claims description 15
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 13
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 13
- 238000002137 ultrasound extraction Methods 0.000 claims description 13
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 239000000377 silicon dioxide Substances 0.000 claims description 12
- 235000012239 silicon dioxide Nutrition 0.000 claims description 12
- 241000972672 Phellodendron Species 0.000 claims description 11
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000005520 cutting process Methods 0.000 claims description 11
- 238000005360 mashing Methods 0.000 claims description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 10
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 10
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- 239000002270 dispersing agent Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 241000219823 Medicago Species 0.000 claims description 6
- 241001071917 Lithospermum Species 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 5
- 235000005087 Malus prunifolia Nutrition 0.000 claims description 5
- 244000070406 Malus silvestris Species 0.000 claims description 5
- 239000012752 auxiliary agent Substances 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 4
- ORLPWCUCEDVJNN-UHFFFAOYSA-N sodium;tetradecyl benzenesulfonate Chemical compound [Na].CCCCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 ORLPWCUCEDVJNN-UHFFFAOYSA-N 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 2
- 241000125175 Angelica Species 0.000 claims 1
- 244000044283 Toxicodendron succedaneum Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 abstract description 124
- 206010052428 Wound Diseases 0.000 abstract description 122
- 240000004658 Medicago sativa Species 0.000 abstract description 36
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000035876 healing Effects 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 241000222122 Candida albicans Species 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 229940095731 candida albicans Drugs 0.000 abstract description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 4
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 48
- -1 flavonoid compounds Chemical class 0.000 description 36
- 241001092040 Crataegus Species 0.000 description 35
- 241001570521 Lonicera periclymenum Species 0.000 description 29
- 230000000694 effects Effects 0.000 description 23
- 244000061520 Angelica archangelica Species 0.000 description 20
- 238000000034 method Methods 0.000 description 19
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 17
- 238000001704 evaporation Methods 0.000 description 17
- 239000007864 aqueous solution Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000001976 improved effect Effects 0.000 description 12
- 244000025254 Cannabis sativa Species 0.000 description 11
- 241000972673 Phellodendron amurense Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 241000219061 Rheum Species 0.000 description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 10
- 229940076810 beta sitosterol Drugs 0.000 description 10
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 10
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 10
- 229950005143 sitosterol Drugs 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 9
- 229930003935 flavonoid Natural products 0.000 description 9
- 235000017173 flavonoids Nutrition 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 230000029663 wound healing Effects 0.000 description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 238000000227 grinding Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 7
- 229940032091 stigmasterol Drugs 0.000 description 7
- 235000016831 stigmasterol Nutrition 0.000 description 7
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 238000003809 water extraction Methods 0.000 description 7
- QKNDCRMJDZLFEG-UHFFFAOYSA-N 7-Methoxyflavone Chemical compound C=1C(OC)=CC=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 QKNDCRMJDZLFEG-UHFFFAOYSA-N 0.000 description 6
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 6
- 229940015301 baicalein Drugs 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 229930182830 galactose Natural products 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 6
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone powder Natural products C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 6
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 235000021314 Palmitic acid Nutrition 0.000 description 5
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 4
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 4
- GPDJGLOROGNHJD-UHFFFAOYSA-N 5,6,7-trihydroxy-2-phenyl-2,3-dihydrochromen-4-one Chemical compound C1C(=O)C=2C(O)=C(O)C(O)=CC=2OC1C1=CC=CC=C1 GPDJGLOROGNHJD-UHFFFAOYSA-N 0.000 description 4
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 4
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 4
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 4
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 4
- 235000000431 campesterol Nutrition 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- 235000001368 chlorogenic acid Nutrition 0.000 description 4
- 229940074393 chlorogenic acid Drugs 0.000 description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 4
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 4
- 235000009498 luteolin Nutrition 0.000 description 4
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 4
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 4
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 4
- ZFKKRRMUPBBYRS-UHFFFAOYSA-N norwogonin Chemical compound OC=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 ZFKKRRMUPBBYRS-UHFFFAOYSA-N 0.000 description 4
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 4
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 3
- 241000208838 Asteraceae Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- 241000729196 Lycopus lucidus Species 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 3
- 229940093265 berberine Drugs 0.000 description 3
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 3
- 235000004883 caffeic acid Nutrition 0.000 description 3
- 229940074360 caffeic acid Drugs 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 150000004775 coumarins Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 2
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- AURKDPLYMRHYAY-UHFFFAOYSA-N (+)-beta-caryophyllene-8,9-epoxy Natural products CC1=CCCC2(CO2)C3CC(C)(C)C3CC1 AURKDPLYMRHYAY-UHFFFAOYSA-N 0.000 description 2
- QUAPPCXFYKSDSV-LBPRGKRZSA-N (2s)-5,7-dihydroxy-6-methoxy-2-phenyl-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2OC3=CC(O)=C(C(=C3C(=O)C2)O)OC)=CC=CC=C1 QUAPPCXFYKSDSV-LBPRGKRZSA-N 0.000 description 2
- XQINTCORIZHGFD-AWEZNQCLSA-O (6as)-1,2,10-trimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-6-ium-11-ol Chemical compound C1=C(OC)C(OC)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 XQINTCORIZHGFD-AWEZNQCLSA-O 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- GFAZGHREJPXDMH-UHFFFAOYSA-N 1,3-dipalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC GFAZGHREJPXDMH-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- VHVMXWZXFBOANQ-UHFFFAOYSA-N 1-Penten-3-ol Chemical compound CCC(O)C=C VHVMXWZXFBOANQ-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- PJLHTVIBELQURV-UHFFFAOYSA-N 1-pentadecene Chemical compound CCCCCCCCCCCCCC=C PJLHTVIBELQURV-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- KCIZTNZGSBSSRM-UHFFFAOYSA-N 3,4,5-Trimethoxytoluene Chemical compound COC1=CC(C)=CC(OC)=C1OC KCIZTNZGSBSSRM-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 2
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 2
- IHLSBQVBFDTNTC-UHFFFAOYSA-N 5-hydroxy-7,8-dimethoxy-2-phenylchromen-4-one Chemical compound COC=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 IHLSBQVBFDTNTC-UHFFFAOYSA-N 0.000 description 2
- CQSRUKJFZKVYCY-OYLIUYJJSA-N 5alpha-24E-ethylidene-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1C2[C@@H]2CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]2(C)CC1 CQSRUKJFZKVYCY-OYLIUYJJSA-N 0.000 description 2
- IVCZEZUJCMWBBR-UHFFFAOYSA-N 7-O-beta-D-glucopyranosyl-7,3',4'-trihydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 IVCZEZUJCMWBBR-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 241001573881 Corolla Species 0.000 description 2
- 235000014493 Crataegus Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241001478385 Eupatorium japonicum Species 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 235000007270 Gaultheria hispida Nutrition 0.000 description 2
- 241001312741 Gekko swinhonis Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- DHHFDKNIEVKVKS-RYGANQNKSA-N Isobetanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C/1C=C(C(O)=O)N[C@@H](C(O)=O)C\1 DHHFDKNIEVKVKS-RYGANQNKSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 2
- 235000010624 Medicago sativa Nutrition 0.000 description 2
- 235000009134 Myrica cerifera Nutrition 0.000 description 2
- 244000269152 Myrica pensylvanica Species 0.000 description 2
- 235000012851 Myrica pensylvanica Nutrition 0.000 description 2
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 2
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 2
- YIJNZIXWHVONBS-ZZXKWVIFSA-N Precarthamin Chemical compound OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C(C(O)\C=C\C=2C=CC(O)=CC=2)=C1O YIJNZIXWHVONBS-ZZXKWVIFSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- YSKVBPGQYRAUQO-UHFFFAOYSA-N Schottenol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CCC21 YSKVBPGQYRAUQO-UHFFFAOYSA-N 0.000 description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 229960002045 bergapten Drugs 0.000 description 2
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 2
- IWTJDVBNIUPPPB-UHFFFAOYSA-N beta-Sitosterol palmitate Chemical compound C12CCC3(C)C(C(C)CCC(CC)C(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCC)C2 IWTJDVBNIUPPPB-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- PTOJXIKSKSASRB-UHFFFAOYSA-O candicine Chemical compound C[N+](C)(C)CCC1=CC=C(O)C=C1 PTOJXIKSKSASRB-UHFFFAOYSA-O 0.000 description 2
- 235000015838 chrysin Nutrition 0.000 description 2
- 229940043370 chrysin Drugs 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- ZGFASEKBKWVCGP-UHFFFAOYSA-N cyclocoumarol Chemical compound C12=CC=CC=C2OC(=O)C2=C1OC(OC)(C)CC2C1=CC=CC=C1 ZGFASEKBKWVCGP-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- CTMLKIKAUFEMLE-RYGANQNKSA-N isobetanin Natural products OC[C@H]1O[C@@H](Oc2cc3C[C@H](N(C=CC4=CC(=N[C@H](C4)C(=O)O)C(=O)O)c3cc2O)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O CTMLKIKAUFEMLE-RYGANQNKSA-N 0.000 description 2
- 235000017088 isobetanin Nutrition 0.000 description 2
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 2
- QZOVLVSTWSTHQN-UHFFFAOYSA-N luteolin 7-O-glucoside Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(C(=O)c3c2)c4ccc(O)c(O)c4)C(O)C(O)C1O QZOVLVSTWSTHQN-UHFFFAOYSA-N 0.000 description 2
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 2
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- ZTHLHHDJRXJGRX-UHFFFAOYSA-N neglectein Natural products C=1C(=O)C=2C(O)=C(O)C(OC)=CC=2OC=1C1=CC=CC=C1 ZTHLHHDJRXJGRX-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LKOJGSWUMISDOF-UHFFFAOYSA-N oroxylin A Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=CC=C1 LKOJGSWUMISDOF-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 229940098695 palmitic acid Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 125000005506 phthalide group Chemical group 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- UVYRSIWRPCSELS-UHFFFAOYSA-N precarthamin Natural products OCC1OC(C(O)C(O)C1O)C2(O)C(=C(C(C(=O)O)C3=C(O)C(O)(C4OC(CO)C(O)C(O)C4O)C(=C(C(=O)C=Cc5ccc(O)cc5)C3=O)O)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O UVYRSIWRPCSELS-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 229930194301 safflor yellow Natural products 0.000 description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 229920001897 terpolymer Polymers 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- RRNYEHFRYMNLOD-HNNXBMFYSA-N (2S)-2,5,6,7-tetrahydroxy-2-phenyl-3H-chromen-4-one Chemical compound O[C@@]1(OC2=CC(=C(C(=C2C(C1)=O)O)O)O)C1=CC=CC=C1 RRNYEHFRYMNLOD-HNNXBMFYSA-N 0.000 description 1
- NBQYBZYBTNQEQG-LSDHHAIUSA-N (2r,3r)-2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=C(O)C=CC=C1O NBQYBZYBTNQEQG-LSDHHAIUSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- AJWRNFIZKHPOHC-JEGFTUTRSA-N (3e,5z)-1,3,5-tridecatriene-7,9,11-triyne Chemical compound CC#CC#CC#C\C=C\C=C\C=C AJWRNFIZKHPOHC-JEGFTUTRSA-N 0.000 description 1
- GQVMHMFBVWSSPF-SOYUKNQTSA-N (4E,6E)-2,6-dimethylocta-2,4,6-triene Chemical compound C\C=C(/C)\C=C\C=C(C)C GQVMHMFBVWSSPF-SOYUKNQTSA-N 0.000 description 1
- XFZBIINLEPBMDY-NERFDCTISA-N (8z,11z)-heptadeca-1,8,11-triene Chemical compound CCCCC\C=C/C\C=C/CCCCCC=C XFZBIINLEPBMDY-NERFDCTISA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PXQLZFYDZKYLPY-UHFFFAOYSA-N (E)-1,3-Tridecadiene-5,7,9,11-tetrayne Natural products CC#CC#CC#CC#CC=CC=C PXQLZFYDZKYLPY-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- PJKIDPZFWKRJPC-FUQOUUGISA-N (E,2R,3R,4R)-4-[(1R)-1,2-dihydroxyethyl]-2,3,4-trihydroxy-7-(4-hydroxy-3-methoxyphenyl)-5-oxohept-6-enal Chemical compound C(\C=C\C1=CC(OC)=C(O)C=C1)(=O)[C@@]([C@@H]([C@H](C=O)O)O)(O)[C@H](O)CO PJKIDPZFWKRJPC-FUQOUUGISA-N 0.000 description 1
- AJWRNFIZKHPOHC-UHFFFAOYSA-N (E,E)-1,3,5-tridecatriene-7,9,11-triyne Natural products CC#CC#CC#CC=CC=CC=C AJWRNFIZKHPOHC-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PXQLZFYDZKYLPY-FNORWQNLSA-N (z)-1,3-tridecadiene-5,7,9,11-tetrayne Chemical compound CC#CC#CC#CC#C\C=C\C=C PXQLZFYDZKYLPY-FNORWQNLSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- XQINTCORIZHGFD-UHFFFAOYSA-O 1,2,10-trimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-6-ium-11-ol Chemical compound C1=C(OC)C(OC)=C2C3=C(O)C(OC)=CC=C3CC3[N+](C)(C)CCC1=C23 XQINTCORIZHGFD-UHFFFAOYSA-O 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- FIMVMYXUGWSJKE-UHFFFAOYSA-N 1,4-xylene Chemical compound CC1=CC=C(C)C=C1.CC1=CC=C(C)C=C1 FIMVMYXUGWSJKE-UHFFFAOYSA-N 0.000 description 1
- ZNEMGFATAVGQSF-UHFFFAOYSA-N 1-(2-amino-6,7-dihydro-4H-[1,3]thiazolo[4,5-c]pyridin-5-yl)-2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound NC=1SC2=C(CN(CC2)C(CC=2OC(=NN=2)C=2C=NC(=NC=2)NC2CC3=CC=CC=C3C2)=O)N=1 ZNEMGFATAVGQSF-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- DFQBFBKAUJTOJI-UHFFFAOYSA-N 1-phenyl-3-(2,4,6,6-tetrahydroxy-2-methoxycyclohex-3-en-1-yl)prop-2-en-1-one Chemical compound OC1(C(C(C=C(C1)O)(OC)O)C=CC(=O)C1=CC=CC=C1)O DFQBFBKAUJTOJI-UHFFFAOYSA-N 0.000 description 1
- VIMNVTXRTVHTBP-UHFFFAOYSA-N 2,3,5,7-tetrahydroxy-2-phenyl-3h-chromen-4-one Chemical compound OC1C(=O)C2=C(O)C=C(O)C=C2OC1(O)C1=CC=CC=C1 VIMNVTXRTVHTBP-UHFFFAOYSA-N 0.000 description 1
- WOCPKEVGZHJLEK-UHFFFAOYSA-N 2,5,5,7-tetrahydroxy-6,8-dimethoxy-2-phenyl-3,4a-dihydrochromen-4-one Chemical compound OC1(C2C(CC(OC2=C(C(=C1OC)O)OC)(C1=CC=CC=C1)O)=O)O WOCPKEVGZHJLEK-UHFFFAOYSA-N 0.000 description 1
- AJPJJICZVBGWEX-UHFFFAOYSA-N 2-methylbutanoic acid Chemical compound CCC(C)C(O)=O.CCC(C)C(O)=O AJPJJICZVBGWEX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- ZAIANDVQAMEDFL-UHFFFAOYSA-N 3-methoxy-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(OC)=C1C1=CC=CC=C1 ZAIANDVQAMEDFL-UHFFFAOYSA-N 0.000 description 1
- OXDRRSIWCCBLOE-UHFFFAOYSA-N 3-methylbutanoic acid Chemical compound CC(C)CC(O)=O.CC(C)CC(O)=O OXDRRSIWCCBLOE-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- IBRZMSRKXBEGNR-MBZLXOAWSA-N C(/CCC(=C)C=C)=C(/C)\CCC=C(C)C.C(/CCC(=C)C=C)=C(/C)\CCC=C(C)C Chemical compound C(/CCC(=C)C=C)=C(/C)\CCC=C(C)C.C(/CCC(=C)C=C)=C(/C)\CCC=C(C)C IBRZMSRKXBEGNR-MBZLXOAWSA-N 0.000 description 1
- ZWBAXEAZLNPFRV-FLYFVYFHSA-N C(\C=C\CCC)O.C(\C=C\CCC)=O Chemical compound C(\C=C\CCC)O.C(\C=C\CCC)=O ZWBAXEAZLNPFRV-FLYFVYFHSA-N 0.000 description 1
- WYLIRYQDDKDHLT-UHFFFAOYSA-N CC1=CC=CC=C1C.CC1=CC=CC=C1C Chemical compound CC1=CC=CC=C1C.CC1=CC=CC=C1C WYLIRYQDDKDHLT-UHFFFAOYSA-N 0.000 description 1
- MIGXRXJVZMOHES-UHFFFAOYSA-N CC1CCC2C(C)(C)C3CC12CC=C3C.CC3CCC1C(C)(C)C2CC31CC=C2C Chemical compound CC1CCC2C(C)(C)C3CC12CC=C3C.CC3CCC1C(C)(C)C2CC31CC=C2C MIGXRXJVZMOHES-UHFFFAOYSA-N 0.000 description 1
- JXRNMQDTJAQLAQ-ZBJPFNDPSA-N CCC=CC/C=C\C/C=C\CCCCCC=C Chemical compound CCC=CC/C=C\C/C=C\CCCCCC=C JXRNMQDTJAQLAQ-ZBJPFNDPSA-N 0.000 description 1
- OSSASFCYPCFKQV-HGWFLFNWSA-N CCCCC\C=C\C=C\C=O.CCCCC\C=C\C=C\C=O Chemical compound CCCCC\C=C\C=C\C=O.CCCCC\C=C\C=C\C=O OSSASFCYPCFKQV-HGWFLFNWSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 240000001825 Chimonanthus praecox Species 0.000 description 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- VLXDPFLIRFYIME-GZBLMMOJSA-N Copaene Natural products C1C=C(C)[C@H]2[C@]3(C)CC[C@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-GZBLMMOJSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- IMKHDCBNRDRUEB-UHFFFAOYSA-N Dihydroactinidiolide Natural products C1CCC(C)(C)C2=CC(=O)OC21C IMKHDCBNRDRUEB-UHFFFAOYSA-N 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000758993 Equisetidae Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 244000062748 Eupatorium adenophorum Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- PHHAXWBLJNBVNS-UHFFFAOYSA-N Isoglycycoumarin Natural products C=1C=2C(OC)=C3CCC(C)(C)OC3=CC=2OC(=O)C=1C1=CC=C(O)C=C1O PHHAXWBLJNBVNS-UHFFFAOYSA-N 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- HKSMPQLLDLOZBZ-UHFFFAOYSA-N O1C=CC=C1.OCC(O)CO Chemical compound O1C=CC=C1.OCC(O)CO HKSMPQLLDLOZBZ-UHFFFAOYSA-N 0.000 description 1
- GUIYORVNNIUEBH-SXMAHZFBSA-N Obacunoic acid Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@H]([C@]4(C)\C=C/C(O)=O)C(C)(O)C)C=COC=1 GUIYORVNNIUEBH-SXMAHZFBSA-N 0.000 description 1
- GUIYORVNNIUEBH-UHFFFAOYSA-N Obacunoic acid Natural products OC(=O)C=CC1(C)C(C(C)(O)C)CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 GUIYORVNNIUEBH-UHFFFAOYSA-N 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- QXIPXNZUEQYPLZ-UHFFFAOYSA-N Oroxylosid Natural products C1=C2OC(C=3C=CC=CC=3)=CC(=O)C2=C(O)C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O QXIPXNZUEQYPLZ-UHFFFAOYSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 241000244269 Peucedanum Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- BMLZFLQMBMYVHG-UHFFFAOYSA-N Phellopterin Chemical compound O1C(=O)C=CC2=C1C(OCC=C(C)C)=C1OC=CC1=C2OC BMLZFLQMBMYVHG-UHFFFAOYSA-N 0.000 description 1
- XXARIFJTXNCWNT-UHFFFAOYSA-N Phellopterin Natural products COc1c2C=CC(=O)Oc2c(OC=CC(C)C)c3occc13 XXARIFJTXNCWNT-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229930192484 Skullcapflavone Natural products 0.000 description 1
- CZRGNFVQUYWGKP-UHFFFAOYSA-N Skullcapflavone I Natural products COC=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1O CZRGNFVQUYWGKP-UHFFFAOYSA-N 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UZXMLGUMBQQVME-UHFFFAOYSA-N Swietenocoumarin B Natural products O1C(=O)C=CC2=C1C(CC=C(C)C)=C1OC=CC1=C2OC UZXMLGUMBQQVME-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- BJBKXYIIWYIZCX-UHFFFAOYSA-N Trigraecum Natural products C1=C(O)C(OC)=CC(C(C=2)=O)=C1OC=2C1=CC=CC=C1 BJBKXYIIWYIZCX-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IWTJDVBNIUPPPB-FPNUYMRSSA-N beta-Sitosterol palmitate Natural products C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CC[C@@H](CC)C(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC)C1 IWTJDVBNIUPPPB-FPNUYMRSSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GQVMHMFBVWSSPF-UHFFFAOYSA-N cis-alloocimene Natural products CC=C(C)C=CC=C(C)C GQVMHMFBVWSSPF-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- VLXDPFLIRFYIME-BTFPBAQTSA-N copaene Chemical compound C1C=C(C)[C@H]2[C@]3(C)CC[C@@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-BTFPBAQTSA-N 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- JDPQWHLMBJZURR-UHFFFAOYSA-N decan-5-one Chemical compound CCCCCC(=O)CCCC JDPQWHLMBJZURR-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- IMKHDCBNRDRUEB-LLVKDONJSA-N dihydroactinidiolide Chemical compound C1CCC(C)(C)C2=CC(=O)O[C@@]21C IMKHDCBNRDRUEB-LLVKDONJSA-N 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- XTCQUBCCCSJAKJ-UHFFFAOYSA-N ethylbenzene Chemical compound CCC1=CC=CC=C1.CCC1=CC=CC=C1 XTCQUBCCCSJAKJ-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- VKQRFUTZCXPPPY-UHFFFAOYSA-N heptadec-1-ene Chemical compound C=CCCCCCCCCCCCCCCC.C=CCCCCCCCCCCCCCCC VKQRFUTZCXPPPY-UHFFFAOYSA-N 0.000 description 1
- PAEASVRMKPAASA-UHFFFAOYSA-N hexadec-1-ene Chemical compound CCCCCCCCCCCCCCC=C.CCCCCCCCCCCCCCC=C PAEASVRMKPAASA-UHFFFAOYSA-N 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- ASFLDIVAXZKKSO-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O.CCCCC(C)O ASFLDIVAXZKKSO-UHFFFAOYSA-N 0.000 description 1
- LSXRQJWRXAOUIA-UHFFFAOYSA-N hexan-3-ol Chemical compound CCCC(O)CC.CCCC(O)CC LSXRQJWRXAOUIA-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229940071490 hordenine Drugs 0.000 description 1
- KUBCEEMXQZUPDQ-UHFFFAOYSA-N hordenine hydrochloride Natural products CN(C)CCC1=CC=C(O)C=C1 KUBCEEMXQZUPDQ-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- NHXTZGXYQYMODD-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCC(O)=O NHXTZGXYQYMODD-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- JDEHKSHYQXNASH-UHFFFAOYSA-N kaempferol-3-O-beta-D-glucopyranoside Natural products OCC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O JDEHKSHYQXNASH-UHFFFAOYSA-N 0.000 description 1
- ZZZILDYSXRHUNY-UHFFFAOYSA-N kaempferol-3-O-glucoside Natural products OC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O ZZZILDYSXRHUNY-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- STKUCSFEBXPTAY-GSUVRYNNSA-N methyl (4s,5z,6s)-5-ethylidene-4-[2-oxo-2-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]ethyl]-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4h-pyran-3-carboxylate Chemical compound O([C@@H]\1OC=C([C@H](C/1=C/C)CC(=O)OC[C@@H]1[C@H]([C@H](O)[C@@H](O)[C@H](OCCC=2C=CC(O)=CC=2)O1)O)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O STKUCSFEBXPTAY-GSUVRYNNSA-N 0.000 description 1
- ZAJNGDIORYACQU-UHFFFAOYSA-N methyl n-octyl ketone Natural products CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- QXIPXNZUEQYPLZ-QSUZLTIMSA-N oroxylin A 7-O-beta-D-glucuronide Chemical compound C1=C2OC(C=3C=CC=CC=3)=CC(=O)C2=C(O)C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O QXIPXNZUEQYPLZ-QSUZLTIMSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- XGPBRZDOJDLKOT-UHFFFAOYSA-N praeruptorin A Natural products C1=CC(=O)OC2=C1C=CC1=C2C(OC(C)=O)C(OC(=O)C(C)=CC)C(C)(C)O1 XGPBRZDOJDLKOT-UHFFFAOYSA-N 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及到新技术领域,具体涉及到一种温和型伤口消毒液及其制备工艺。所述温和型伤口消毒液的制备原料包括苏木、黄瓜、红花、黄岑、新疆紫草、白芷、马齿苋、泽兰、紫花苜蓿、山楂、黄柏、大黄、蒲公英、金银花、小腊树叶、当归。对金黄色葡萄球菌、大肠杆菌、白色念珠菌、绿脓杆菌等易于感染伤口的细菌有很好的抑菌、杀菌效果,可以避免伤口的感染。而且对伤口有明显的促进愈合作用,明显缩短伤口的愈合时间。
Description
技术领域
本发明涉及到新技术领域,具体涉及到一种温和型伤口消毒液及其制备工艺。
背景技术
皮肤、创面的愈合通常包括四个连续并重叠的阶段:凝血阶段、炎症阶段、上皮再生,肉芽组织修复阶段,以及组织重塑阶段。在受伤早期,大量血小板聚集在损伤部位,形成纤维蛋白凝块,减少活动性出血;炎症期出现中性粒细胞等炎症因子在伤口处聚集,白细胞吞噬细菌和细胞碎片,并释放细胞因子,促成成纤维细胞、血管内皮细胞等细胞的迁移和分化;修复期大量毛细血管生成,成纤维细胞分泌细胞外基质形成肉芽组织;角质形成细胞大量增殖,上皮爬行,逐渐覆盖创面,伤口收缩,细胞逐渐凋亡,创面愈合进入重塑期,伤口逐渐愈合。创面愈合的过程极易受到阻断或破坏,导致比较难愈合性创面的形成。感染、血管性疾病、肿瘤、糖尿病等疾病都能对创面愈合过程造成干扰。糖尿病创面的愈合在炎症期和增殖期存在不同程度的修复紊乱,创面持续的过度炎症反应阻碍了细胞外基质的沉淀,导致创面愈合的延缓。目前,国内外关于糖尿病比较难愈合性创面的研究主要围绕着信号通路、血管生成、神经肽、基质金属蛋白酶和细胞凋亡等方面展开。
发明内容
为了解决上述技术问题,本发明的第一个方面提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木、黄瓜、红花、黄岑、新疆紫草、白芷、马齿苋、泽兰、紫花苜蓿、山楂、黄柏、大黄、蒲公英、金银花、小腊树叶、当归。
作为本发明一种优选的技术方案,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20~32、黄瓜20~35、红花26~39、黄岑18~30、新疆紫草23~35、白芷25~35、马齿苋20~41、泽兰22~38、紫花苜蓿24~28、山楂25~45、黄柏26~42、大黄25~35、蒲公英24~37、金银花26~42、小腊树叶26~35、当归21~32。
作为本发明一种优选的技术方案,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20~26、黄瓜25~30、红花27~31、黄岑18~24、新疆紫草23~38、白芷25~30、马齿苋22~28、泽兰22~27、紫花苜蓿24~28、山楂25~32、黄柏26~34、大黄25~30、蒲公英24~31、金银花26~30、小腊树叶26~33、当归21~27。
作为本发明一种优选的技术方案,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20、黄瓜27、红花30、黄岑21、新疆紫草24、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25。
本发明第二个方面提供了温和型伤口消毒液的制备方法,至少包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后加入50wt%乙醇水溶液加热回流,过滤,浓缩滤液得到粘稠物A;
(2)提取所需重量的一半的小腊树叶和所需量的黄瓜后过滤,滤液浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入蒸馏水加热回流,过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入75wt%乙醇水溶液,搅拌混合微波提取,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入60wt%乙醇水溶液和0.5~2.5wt%分散剂搅拌混合,然后在250w功率下超声提取,过滤,浓缩滤液得到E;
(6)取所需重量的一半的苏木烘干粉碎后加入石油醚,加热回流,过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1~3wt%的助剂和85wt%乙醇水溶液,调节pH值,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,加入蒸馏水,加热回流,过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和乙酸乙酯后加热回流,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释后进行无菌处理,得到所述的温和型伤口消毒液。
作为本发明一种优选的技术方案,第(4)步骤中在所述黄岑和大黄烘干后还要加入第(3)步骤中所述新疆紫草滤渣粉末,然后微波提取。
作为本发明一种优选的技术方案,第(6)步骤中所述助剂为无水硫酸钠和/或无水硫酸镁。
作为本发明一种优选的技术方案,第(6)步骤中的pH值控制在4~6。
作为本发明一种优选的技术方案,第(2)步骤中小腊树叶和黄瓜的提取过程包括如下步骤:取所需重量一半的小腊树叶和黄瓜切碎后加入二氧化硅,捣碎,然后加入蒸馏水在80℃下焖煮,过滤,浓缩滤液,得到粘稠物B。
作为本发明一种优选的技术方案,第(5)步骤中所述的分散剂选自十四烷基苯磺酸钠、聚乙二醇、十二烷基苯磺酸钠、硫酸铵中的一种或多种。
有益效果:本发明提供的温和型伤口消毒液与现有的消毒液相比,采用天然植物作为制备原料,具有作用过程温和,对伤口不产生不必要的刺激,体验舒适等特点。由于本发明提供的温和型伤口消毒液中含有多种活血化瘀、清热解毒、消炎止痛的化学成分,能够抑制伤口周围的有害细菌的生长,杀灭大部分有害细菌,避免伤口感染的同时还可以起到排脓生肌,促进伤口的愈合,缩短伤口愈合的时间等效果。此外本申请提供的制备方法操作简单,抑菌杀菌效果好而且持久,对伤口和人体无毒副作用,对环境不产生污染。
具体实施方式
参选以下本发明的优选实施方法的详述以及包括的实施例可更容易地理解本发明的内容。除非另有限定,本文使用的所有技术以及科学术语具有与本发明所属领域普通技术人员通常理解的相同的含义。当存在矛盾时,以本说明书中的定义为准。
如本文所用术语“由…制备”与“包含”同义。本文中所用的术语“包含”、“包括”、“具有”、“含有”或其任何其它变形,意在覆盖非排它性的包括。例如,包含所列要素的组合物、步骤、方法、制品或装置不必仅限于那些要素,而是可以包括未明确列出的其它要素或此种组合物、步骤、方法、制品或装置所固有的要素。
连接词“由…组成”排除任何未指出的要素、步骤或组分。如果用于权利要求中,此短语将使权利要求为封闭式,使其不包含除那些描述的材料以外的材料,但与其相关的常规杂质除外。当短语“由…组成”出现在权利要求主体的子句中而不是紧接在主题之后时,其仅限定在该子句中描述的要素;其它要素并不被排除在作为整体的所述权利要求之外。
当量、浓度、或者其它值或参数以范围、优选范围、或一系列上限优选值和下限优选值限定的范围表示时,这应当被理解为具体公开了由任何范围上限或优选值与任何范围下限或优选值的任一配对所形成的所有范围,而不论该范围是否单独公开了。例如,当公开了范围“1至5”时,所描述的范围应被解释为包括范围“1至4”、“1至3”、“1至2”、“1至2和4至5”、“1至3和5”等。当数值范围在本文中被描述时,除非另外说明,否则该范围意图包括其端值和在该范围内的所有整数和分数。
单数形式包括复数讨论对象,除非上下文中另外清楚地指明。“任选的”或者“任意一种”是指其后描述的事项或事件可以发生或不发生,而且该描述包括事件发生的情形和事件不发生的情形。
说明书和权利要求书中的近似用语用来修饰数量,表示本发明并不限定于该具体数量,还包括与该数量接近的可接受的而不会导致相关基本功能的改变的修正的部分。相应的,用“大约”、“约”等修饰一个数值,意为本发明不限于该精确数值。在某些例子中,近似用语可能对应于测量数值的仪器的精度。在本申请说明书和权利要求书中,范围限定可以组合和/或互换,如果没有另外说明这些范围包括其间所含有的所有子范围。
此外,本发明要素或组分前的不定冠词“一种”和“一个”对要素或组分的数量要求(即出现次数)无限制性。因此“一个”或“一种”应被解读为包括一个或至少一个,并且单数形式的要素或组分也包括复数形式,除非所述数量明显旨指单数形式。
“聚合物”意指通过聚合相同或不同类型的单体所制备的聚合化合物。通用术语“聚合物”包含术语“均聚物”、“共聚物”、“三元共聚物”与“共聚体”。
“共聚体”意指通过聚合至少两种不同单体制备的聚合物。通用术语“共聚体”包括术语“共聚物”(其一般用以指由两种不同单体制备的聚合物)与术语“三元共聚物”(其一般用以指由三种不同单体制备的聚合物)。其亦包含通过聚合四或更多种单体而制造的聚合物。“共混物”意指两种或两种以上聚合物通过物理的或化学的方法共同混合而形成的聚合物。
为了解决上述技术问题,本发明的第一个方面提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木、黄瓜、红花、黄岑、新疆紫草、白芷、马齿苋、泽兰、紫花苜蓿、山楂、黄柏、大黄、蒲公英、金银花、小腊树叶、当归。
苏木:苏木异名苏枋、苏方、苏方木、赤木、红柴,为豆科植物苏木Caesalpiniasappan L.(Leguminosae)的干燥心材。在我国主要分布于广西、广东、台湾、贵州、云南、四川等地。全年可采,除去外皮及边材,取心材,晒干。药性甘,咸,平,无毒。其化学成分含1-羟基-7-甲氧基呫吨酮、2-羟基呫吨酮、1,5-二羟基呫吨酮、1,7-二羟基呫吨酮、大黄酚、木栓酮、熊果酸、β-谷甾醇棕榈酸酯、豆甾醇、β-谷甾醇等。可用于治疗跌打损伤,破伤风痛经,产后瘀阻,心腹痛,产后血晕,痈肿等。其具有祛痰、消肿止痛、活血祛瘀、散风等功效。
黄芩:别名山茶根、土金茶根,是唇形科黄芩属多年生草本植物;肉质根茎肥厚,叶坚纸质,披针形至线状披针形,总状花序在茎及枝上顶生,花冠紫、紫红至蓝色,花丝扁平,花柱细长,花盘环状,子房褐色,小坚果卵球形,花果期7~9月。黄芩含黄酮类化合物:黄芩素(baicalein),黄芩新素(neobaicalein),即黄芩黄酮Ⅱ(skullcapflavoneⅡ),黄芩甙(baicalin),汉黄芩素(wogonin),汉黄芩甙(wogono-side),木蝴蝶素A(oroxylin,oroxylin A),7-甲氧基黄芩素(7-methoxbaic alien),黄芩黄酮(skullcapflavone)Ⅰ,二氢木蝴蝶素A(dihydrooroxylin A),白杨素(chrysin),2,5,8-三羟基-7-甲氧基黄酮(2,5,8-trihydroxy-7-methoxy-flavone),2,5,8-三羟基-6,7-二甲氧基黄酮(2,5,8-trihydroxy-6,7-dimethoxyflavone),4,5,7-三羟基-6-甲氧基黄烷酮(4,5,7-trhydroxy-6-methoxyflavanone),2,3,5,6,7-五羟基黄烷酮(2,3,5,6,7-pentahydroxyflavanone),汉黄芩素-5-β-D-葡萄糖甙(wogonin-5-β-D-glucoside),2-(3-羟基-4-甲氧基苯基)-乙基-1-O-α-L-鼠李糖基(1→3)-β-D(4-阿魏酰基)-葡萄糖(2-(3-hydroxy-4-methoxyphenyl)ethyl-1-O-α-L-rhamnosyl(1→3)-β-D-(4-feruloyl)glucoside),白杨素-6-C-α-L-阿拉伯糖甙(chrysin-6-C-β-D-glucoside-8-C-β-L-arabinoside),白杨素-6-C-α-L-阿拉伯糖甙-8-C-β-D-葡萄糖甙(chrysin-6-C-α-L-arabi-noside-8-C-β-D-glucoside),(2S)-2,5,6,7-四羟基黄烷酮((2S)-25,6,7-terahydr-oxyflavanone),5,7,2,6-四羟基黄酮(5,7,2,6-tetrahydroxyflavone),5,8-二羟基-6,7-二甲氧基黄酮(5,8-dihydroxy-6,7-drimethoxyflavone),5,7,4-三羟基-8-甲氧基黄酮(5,7,4-trihydroxy-8-methoxyflavone),木蝴蝶素A-7-O-葡萄糖醛酸甙(oroxylinA-7-O-glucuronide),5,7,2-三羟基甲氧基黄酮(5,7,2-trihyroxy-6-methoxy-flavone),5,2-二羟基-6,7,8-三甲氧基黄酮(5,2-dihydroxy-6,7,8-trimethoxy-flavone),5-闳基-7,8-二甲氧基黄酮(5-hydroxy-7,8-dimethoxy-flavone),去甲汉黄芩素(norwogonin),二氢黄芩素(dihydro-baicalin),5,7,2-三羟基黄酮(5,7,2-trihydroxy flavone),5,7,2-三羟基-8,6-二甲氧基黄酮(5,7,2-trihydroxy-8,6-dimethoxy-flavone),5,7,2,5-四羟基-8,6-二甲氧基黄酮即粘毛黄芩素Ⅲ(5,7,2,5-tetrahydroxy-8,6-dimethoxyflavone),visciduiinⅢ,5,2,5-三羟基三甲氧基黄酮(5,2,5-trihy-droxy-6,7,8-trimethoxyflavone),黄芩素-7-O-β-D-吡喃葡萄糖甙(baicalein-7-O-β-D-glucopyranoside),5,7,2-三羟基-8-甲氧基黄酮(5,7,2-trhiyroxy-8-methoxy-flavone),5,7,2,3-四羟基黄酮(5,7,2,3-trihydroxy-6-methoxyflavone),5,7,2,3-四闳基黄酮(5,7,2,3-tetrahydroxyflavone),3,5,7,2,5,6-五羟基黄酮(3,5,7,2,5,6-pentahydroxy flavone)即粘毛黄芩素Ⅰ(viscidulinⅠ),(2S)-7,2,6-三羟基-5-甲氧基黄烷酮((2S)-7,2,6-trihydroxy-5-methoxyflavanone),2,6,2,4-四羟基-6-甲氧基查尔酮(2,6,2,4-tetrahydroxy-6-methoxychalcone),5,7,2,5-四羟基黄酮(5,7,2,5-tetrahydroxy flavone),左旋圣草素(eriodictyol),半枝莲种素(rivularin)及粘毛黄芩素Ⅲ-2-O-β-D-吡喃葡萄糖甙(viscidulinⅢ-2-O-β-D-glucoplyranoside)等。另外还含β-谷甾醇(β-sitosterol),菜油甾醇(campesterol)及豆甾醇(stigmasterol)等成分。可用于治疗疔疮,排脓,黄疸,热淋,吐、衄、崩、漏,目赤肿痛,胎动不安,痈肿疔疮等。具有抗炎、清热燥湿、泻火解毒、止血、安胎等功效。
新疆紫草(Radix Arnebiae):其为紫草科植物新疆紫草[Arnabia euchroma(Royle)Johnst]的干燥的跟。新疆是中国新疆紫草的主要产地,中国药用紫草中70%的原料来自新疆紫草,新疆2003年产量最高达200吨。新疆紫草富含紫草素及其衍生物等萘醌类色素、多糖、酚类、酸类等成分。
马齿苋(Portulaca oleracea L.)为马齿苋科马齿属的一年生肉质草本植物,广泛分布于温带和热带地区,在我国最为常见,是一种食药兼用的植物。其化学成分含去甲肾上腺素、多量钾盐、多巴、多巴胺、甜菜素、异甜菜素、甜菜式、异甜菜甙、草酸、苹果酸、柠檬酸、谷氨酸、天冬氨酸、丙氨酸、葡萄糖、果糖、蔗糖等。可用于治疗热毒血痢,痈肿疔疮,湿疹,丹毒,蛇虫咬伤,便血,痔血,崩漏下血等。具有清热解毒、消肿、止血凉血等功效。
黄柏,为芸香科黄檗属植物黄皮树(Phellodendron-chinense Schneid.)或黄檗(Phellodendron amurense Rupr.)的干燥树皮,前者习称“川黄柏”,后者习称“关黄柏”。现代科学研究表明:黄柏中含有大量生物活性成分,如生物碱、甾醇、内酯及黏液质等。生物碱是黄柏中最重要的活性物质,目前发现的成分有小檗碱(Berberine)、黄柏碱(Phellodendrine)、药根碱(Jatrorrhizine)、蝙蝠葛碱(Menisperine)、掌叶防己碱(巴马亭,Palmatine)、木兰花碱(Magnoflorine)、N-甲基大麦芽碱(Candicine)等。此外黄柏中还含有一些其他的活性物质,如黄柏内酯(Obaculactone)、黄柏酮(Obacunone)、7-脱氢豆甾醇(7-Dehydrostigmasterol)、菜油甾醇(Campesterol)、青萤光酸(Lumicaeruleic acid)、β-谷甾醇(β-Sitosterol)、黄柏酮酸(Obacunonic acid)及白鲜交酯(Dictamnolide)等。
大黄是多种蓼科大黄属的多年生植物的合称,也是中药材的名称,本发明一根茎入药。在中国地区的文献里大黄指的往往是马蹄大黄。大黄粉末中富含大黄酸、大黄素、芦荟大黄素、大黄酚、大黄素甲醚等蒽醌类化合物。
红花,(拉丁学名:Carthamus tinctorius L.),别名:红蓝花、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。
红花含红色的和黄色的色素,从中可以分离得到:红花甙(carthamin),前红花甙(precarthamin),红花黄色素(safflow yellow)A及B,红花明甙(safflominA)A等成分。又含多酚类成分,例如:绿原酸(chlorogenic acid),加啡酸(caffeic acid),儿茶酚(cate-chol),焦性儿茶酚(pyrocatechol),多巴(dopa)。还含挥发性成分八十余种,例如乙酸乙酯(ethyl acetate),苯(benzene),1-戊烯-3-醇(pent-1-en-3-ol),3-已醇(3-hexanol),2-已醇(2-hexanol),(E)-2-已烯醛[(E)-2-hexenal],3-甲基丁酸(3-methyl butyricacid),2-甲基丁酸(2-methy butyric acid),乙苯(ethyl benzene),对二甲苯(p-xylene),邻二甲苯(o-xylene),苯乙醛(phenyl acetaldehyde),壬醛(nonanal),松油烯-4-醇(terpinen-4-ol),马革命烯酮(verbenone),癸醛(decanal),苯并噻唑(benzothia-zole),(E,E)-2,4-癸二烯醛[(E、E)-2,4-decadienal],桂皮酸甲酯(methyl cinnamate),1,2,3-三甲氧基-5-甲基苯(1,2,3-TCMLIBimethoxy-5-methyl-benzene),α-(王古)(王巴)烯(α-copaene),1-二四碳烯(1-teTCMLI Badecene),α-柏木烯(α-cedrene),丁香烯(caryophyllene),(E)-β-金合欢烯[(E)-β-farnesene],葎草烯(humulene),β-紫罗兰酮(β-ionone),β-芹子烯(β-selinene),二氢猕桃内酯(dihydroac-tinidiolide),1-十五碳烯(1-pentadecene),ε-荜澄茄烯(ε-cadinene),丁香烯环氧化物(caryophylleneepoxide),1-十六碳烯(1-hexadecene),1,3,5,11-十三碳四烯-7,9-二炔(1,3,5,11-TCMLIBidecateTCMLIBaene-7,9-diyne),(E,E,E)、(E,Z,E)和(Z,E,E)的三种异构体,(Z,Z)-1,3,11-十三碳三烯-5,7,9-三炔[(Z,Z)-1,3,11-TCMLIBideca-TCMLIBiene-5,7,9-TCMLIBiyen],(Z,Z)-1,8,11-十七碳三烯[(Z、Z)-1,8,11-heptadeca-TCMLIBiene],1,3,11-十三碳三烯-5,7,9-三炔(1,2,33-TCMLIBidecaTCMLIBiene-5,7,9-TCMLIBiyne)的(Z,E)和(E,E)的两种异构体,(Z,Z,Z)-1,8,11,14-十七碳四烯[(Z,Z,Z)-1,8-11,14-hep-tadecateTCMLIBaene],(Z)-1,11-十三碳二烯-3,5,7,9-四炔[(Z)-1,3,5-十三碳三烯-7,9-11-三炔][(E,Z)-1,3,5-TCMLIBidecaTCMLIBiene-7,9,11-TCMLIBiyen],1-十七碳烯(1-heptadecaene),(E)-1,3,5-TCMLIBidecaTCMLIBiene-7,9,11-TCMLIBiyne],1,3-十三碳二烯-5,7,9,11-四炔(1,3-TCMLIBidecadiene-5,7,9-teTCMLIBayne),1,3-十三碳二烯-5,5,7,9-四炔[(E)-1,11-TCMLIBidecadiene-3,5,7,9-teTCMLIBayne],1,3-十三碳二烯-5,7,9,11-四炔(1,3-TCMLIBidecadiene-5,7,9,11-teTCMLIBayne)有(E)和(Z)两种异构体,(E,E)-1,3,5-十三碳三烯-7,9,11-三炔[(E,E)-1,3,5-TCMLIBideca-TCMLI Biene-7,9,11-TCMLIBiyne],3-甲基丁酸-4,6-癸二炔-1-醇酯(deca-4,6-diyn-1-yl3-methylbutyrate),1-十三碳烯-3,5,7,9,11-五炔(1-TCMLI-Bidecene-3,5,7,9,11-pentayne),3-甲基丁酸-(Z)-8-癸烯-4,6-二炔醇-1-酯[(Z)-8-decene-4,6-二炔-1-醇酯[(E,Z)-2,8-decadiene-4,6-diyn-1-yl3-methyl butyrate]等。
除了上述成分外,还含量最少的是带有苯环的和含硫的氨基酸。还含鼠李糖(rhamnose),阿拉伯糖(arabinose),木糖(xylose),葡萄糖(glucose),甘露糖(mannose),二十九烷(nonacosane),β-谷甾醇(β-sitosterol),棕榈酸(palmitic acid),肉豆蔻酸(myristic acid),月桂酸(lauric acid),α,γ-二棕榈酸甘油酯(α,γ-dipalmitin),油酸(oleic acid),亚油酸(linoleic acid),β-谷甾醇-3-O-葡萄糖甙(β-sitosterol-3-O-glucoside)等成分。另含红花多糖,系由葡萄糖,木糖,阿拉伯糖与半乳糖(galactose)等以β-链联接的一种多糖。又含具降血压作用的丙三醇-呋喃阿糖-吡喃葡萄糖甙[propaneTCMLIBiol-α-L-arabino-furanosyl(1-4)-β-D-glucopyrano-side]等。新鲜花蕾含木犀草素-7-O-葡萄糖甙(luteolin-7-O-glucoside),胆甾醇(cholesterol),豆甾醇(stigmasterol),β-谷甾醇,月桂酸,肉豆蔻酸,棕榈酸,亚油酸,硬脂酸(stearic acid),花生酸(arachidic acid)等成分。可用于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛。具有活血通经,散瘀止痛等功效。
白芷多年生高大草本,高1-2.5米,根圆柱形,茎基部径2-5厘米,基生叶一回羽状分裂,复伞形花序顶生或侧生,果实长圆形至卵圆形。以根入药,有祛病除湿、排脓生肌、活血止痛等功能。主治风寒感冒、头痛、鼻炎、牙痛、赤白带下、痛疖肿毒等症,亦可作香料。一般生于林下、林缘、溪旁、灌丛和山谷草地。白芷的水溶性提取物中含有棕榈酸、豆甾醇、β-谷甾醇、β-胡萝卜素等成分;而在脂溶性提取物中含有白当归脑、佛手柑内酯、伞形花内酯等香豆素类化合物等成分。
泽兰,别名又叫地瓜儿苗、地笋、甘露子、方梗泽兰等,为唇形科植物毛叶地瓜儿苗的干燥地上部分。夏、秋季茎叶茂盛时采割,晒干,可全株入药。泽兰茎呈方柱形,少分枝,四面均有浅纵沟,长50~100cm,直径0.2~0.6cm。表面黄绿色或带绿色,节处紫色明显,有白色茸毛;质脆,断面黄白色,髓部中空。叶对生,有短柄;叶片多皱缩,展平后呈披针形或长圆形,长5~10cm;上表面黑绿色,下表面灰绿色,密具腺点,两面均有短毛;先端尖,边缘有锯齿。花簇生叶腋成轮状,花冠多脱落,苞片及花萼宿存,黄褐色,无臭,味淡。地瓜儿苗含有挥发油、葡萄糖甙、鞣质和树脂,还含黄酮甙、酚类、氨基酸、有机酸、皂甙、葡萄糖、半乳糖、泽兰糖、蔗糖、棉子糖、水苏糖、果糖、葡萄糖、半乳糖、泽兰糖、蔗糖、棉子糖、水苏糖、咖啡酸、迷迭香酸、桦木酸、黄酮类化合物、酚酸类化合物、三萜酸类化合物等成分。
紫花苜蓿,(学名:Medicago sativa.)豆科、苜蓿属多年生草本,根粗壮,深入土层,根颈发达。茎直立、丛生以至平卧,四棱形,无毛或微被柔毛,枝叶茂盛。紫花苜蓿含有5种维生素B、维生素C、维生素E、10种矿物质及类黄酮素、类胡萝卜素、酚型酸三种植物特有的营养素等。
山楂,为蔷薇科(Rasaceae)山楂属(Crataegus L.)植物,全世界山楂属植物共有140多种,我国植物志记载共有17种2个变种。黄酮类化合物、原花青素、三帖酸等是山楂中主要的生物活性成分。目前,从山楂中分离得到60余种黄酮类化合物,主要包括以芹菜素和木犀草素为苷元的苷类以及以芦丁、金丝桃苷和槲皮素为主的黄酮醇及氧苷类物质。本发明中的山楂可以用其果实或叶子作为有效成分。
蒲公英,菊科,蒲公英别名黄花地丁、婆婆丁、华花郎等。菊科多年生草本植物。蒲公英有清热解毒,消肿散结,利尿通淋的功效。处方名:蒲公英、公英、鲜公英、黄花地丁。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分。
金银花,又名忍冬(学名:Lonicera japonica)。“金银花”由于忍冬花初开为白色,后转为黄色,因此得名金银花。药材金银花为忍冬科忍冬属植物忍冬及同属植物干燥花蕾或带初开的花。其化学成分含有木犀草素、肌醇、皂甙、绿原酸、异绿原酸、芳樟醇、蒎烯、1-己烯、顺-3-己烯醇-1、顺-2-甲基-2-乙烯基-5、反-2-甲基-2-乙烯基-5、香叶醇、α-松油醇、苯甲醇、苯乙醇、香荆芥酚、丁香油酚等成分。可用于治疗肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、皮肤瘙痒、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等。具有抗炎、清热解毒、部虚疗风等功效。
当归,伞形科,当归根可入药。药性甘,辛,温。其化学成分含挥发油、有机酸和尿嘌呤等成分,有机酸包括阿魏酸、烟酸、丁二酸、香草酸、二十四烷酸、棕榈酸等。可用于治疗跌扑损伤,经闭,痛经,症瘕结聚,崩漏,肌肤麻木,赤痢后重,痈疽疮疡等。具有补血活血,调经止痛,润燥滑肠、抗炎镇痛、免疫等功效。本发明中以当归的根入药。当归中含有二氢呋喃香豆素衍生物、角形呋喃香豆素、吡喃香豆素等香豆素类化合物;木犀草素、芦丁糖苷等黄酮类化合物;烟酸、香草酸等有机酸;别罗勒烯、苯酞类化合物、对甲苯酚等苯酞类化合物等化学成分。
小腊树叶为小腊树的叶子,小腊树属于木犀科,是女贞的一种,常绿灌木或小乔木,本发明中以其叶入药,具有清热利湿,解毒消肿之功效。常用于感冒发热,肺热咳嗽,咽喉肿痛,口舌生疮,湿热黄疸,痢疾,痈肿疮毒,湿疹,皮炎,跌打损伤,烫伤。小腊树叶中含有8’-α-羟基-落叶松脂素4’-O-β-D-吡喃葡萄糖基甙、鹅掌楸苦素、山奈酚-3-O-β-D-吡喃葡萄糖甙,7-O-α-L-吡喃鼠李糖基-山奈酚-3-O-β-D-吡喃葡萄糖甙和山奈甙,10-hydroxyoleuropein,specneuzhenide,3,4-二羟基苯乙醇,3,4-二羟基苯乙醇-2’-O-β-D-吡喃葡萄糖甙,3-甲氧基-苯乙醇-4-O-β-D-吡喃葡萄糖甙等成分。
黄瓜,(学名:Cucumis sativus L.)葫芦科一年生蔓生或攀援草本植物。黄瓜中富含多种糖类(例如葡萄糖,鼠李糖,半乳糖,甘露糖,木糖,果糖)、维生素(维生素C,A,B2,E)、离氨基酸、细纤维素、绿原酸、甙类等成分。
在一种优选的实施方式中,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20~32、黄瓜20~35、红花26~39、黄岑18~30、新疆紫草23~35、白芷25~35、马齿苋20~41、泽兰22~38、紫花苜蓿24~28、山楂25~45、黄柏26~42、大黄25~35、蒲公英24~37、金银花26~42、小腊树叶26~35、当归21~32。
在一种优选的实施方式中,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20~26、黄瓜25~30、红花27~31、黄岑18~24、新疆紫草23~38、白芷25~30、马齿苋22~28、泽兰22~27、紫花苜蓿24~28、山楂25~32、黄柏26~34、大黄25~30、蒲公英24~31、金银花26~30、小腊树叶26~33、当归21~27。
在一种优选的实施方式中,所述温和型伤口消毒液的制备原料,以重量份计,包括苏木20、黄瓜27、红花30、黄岑21、新疆紫草24、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25。
本发明第二个方面提供了温和型伤口消毒液的制备方法,至少包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后加入50wt%乙醇水溶液加热回流,过滤,浓缩滤液得到粘稠物A;
(2)提取所需重量的一半的小腊树叶和所需量的黄瓜后过滤,滤液浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入蒸馏水加热回流,过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入75wt%乙醇水溶液,搅拌混合微波提取,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入60wt%乙醇水溶液和0.5~2.5wt%分散剂搅拌混合,然后在250w功率下超声提取,过滤,浓缩滤液得到E;
(6)取所需重量的一半的苏木烘干粉碎后加入石油醚,加热回流,过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1~3wt%的助剂和85wt%乙醇水溶液,调节pH值,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,加入蒸馏水,加热回流,过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和乙酸乙酯后加热回流,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水后进行无菌处理后,得到所述的温和型伤口消毒液。
在一种优选的实施方式中,所述温和型伤口消毒液的制备方法,至少包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1~3小时,并称热过滤,滤渣中再加入50wt%乙醇水溶液,并加热回流1小时后趁热过滤,两次滤液合并,蒸发浓缩得到膏状物A;
(2)取所需重量一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,并加入4倍重量的蒸馏水,在80℃下焖煮2~4小时,过滤;滤渣中加入4倍重量的蒸馏水在80℃下焖煮2~4小时,过滤,两次过滤所的滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入2~4倍重量的蒸馏水,加热回流1~3小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入第(3)步所得的滤渣粉末和15倍重量的75wt%乙醇水溶液,搅拌混合微波提取30~90min后过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和0.5~2.5wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min~2h后过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入3倍重量的石油醚,加热回流1~3小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末,1~3wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值,加热回流2~4小时,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,加入2~5倍重量的蒸馏水,加热回流2~4小时;趁热过滤,滤液浓缩得到H;将滤渣烘干,并加入所需量的蒲公英、所需重量一半的小腊树叶和蒲公英8倍重量的乙酸乙酯加热回流1~3小时,过滤浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精后消毒,得到所述的温和型伤口消毒液。
本发明中红花、金银花、当归、泽兰和一半重量的苏木进行50wt%乙醇水溶液提取,意料不到的发现这几种成分在提取过程中相互促进提高金银花中木犀草素油等黄酮类有效成分的溶出,也有利于泽兰、红花、当归等原料中酚酸类、黄铜类等有效成分的溶出与扩散,而这些有效成分对白色念珠菌、大肠杆菌等有很强的杀伤力,全面提高伤口消毒液的性能。
本发明中对新疆紫草进行蒸馏水回流提取,可以得到一些水溶性黄酮类、糖类等有效成分,如甘露糖、阿拉伯糖、鼠李糖等,以及一些糖醛酸、蛋白质等化合物,可以抑制伤口补体系统的抑制,有利于抑制炎症反应和伤口组织的进一步损伤。此外,本发明人意想不到的发现,当新疆紫草水提取之后剩余的部分与黄岑和大黄共混后用75wt%乙醇水溶液提取时提取效率更高,而且最终所得的消毒液抑菌效率、伤口愈合性能等效果明显提高。采用微波提取,设置微波功率在500~700发现提取效果最佳。
本发明中的微波是一种电磁波,是由电场和磁场两部分能量组成。本发明中利用微波中的高频电磁波穿透乙醇水溶液中的黄岑、大黄等原料,进入原料内部维管束和腺胞系统,使细胞破裂,细胞内有效成分自由流出。微波生产的电磁场还可以加速原料中的成分向溶剂界面扩散,使有效成分在相对较低的温度下较快的速度溶出,从而最大限度的保证提取的质量。微波提取具有高选择性、操作时间短、有效成分得率高等优点。
本发明人意想不到的发现当黄岑与新疆紫草水提后剩余部分和大黄一起提取时最终制备所得的伤口消毒液的抑菌效果等性能得到明显提高。可能的原因是这三者在75wt%乙醇水溶液中,微波作用下可以促进大黄中大黄素、大黄酸、芦荟大黄素等蒽醌类衍生物的溶出,而这些有效物质可以抑制细菌细胞核酸和蛋白质合成以及糖代谢,阻断细菌的呼吸链,使细菌生长所需能量来源断绝,提高伤口消毒液的抗菌性能。
在一种优选的实施方式中,第(4)步骤中在所述黄岑和大黄烘干后还要加入第(3)步骤中所述新疆紫草滤渣粉末,然后微波提取。
本发明中取规定重量的一半苏木粉碎后进行石油醚提取,再将苏木的石油醚提取物与紫花苜蓿和黄柏一起用乙醇提取,发现提取效果更好,最终制备所得的消毒液性能更佳。可能的原因是,在苏木的石油醚提取物中含有棕榈酸、油酸等脂肪酸类化合物,还有葡萄糖、天冬氨酸、苏氨酸、半乳糖等脂溶性成分,这些成分的加入可以在一定程度上促进小檗碱、黄柏碱、N-甲基大麦芽碱等生物碱活性化合物的溶出与扩散,提高体系中有效成分的提取。此外,在提取过程中加入总粉末质量的1~3wt%的助剂可以促进有效物质的溶出,提高提取效果。可能的原因是黄柏中含有大量的粘液细胞,提取过程中吸水膨胀妨碍其它组织细胞的溶胀及组织中有效成分的溶出和扩散,而助剂的加入可以破坏细胞结构,使细胞内的有效物质充分溶出。
在一种优选的实施方式中,第(6)步骤中所述助剂为无水硫酸钠和/或无水硫酸镁。
本发明人意料不到的发现对黄柏、紫花苜素和苏木石油醚提取物提取过程中调节pH值至偏弱酸性时可以缩短提取时间,提高提取效果。但是体系的酸性太强,pH值低于4时,一些从原料中提取出来的有效成分会沉淀,与未溶解或未发生提取的成分混在一起,被过滤弃掉,反而降低提取效果,一些最终所得的消毒液的性能。
在一种优选的实施方式中,第(6)步骤中的pH值控制在4~6。
本发明中的小腊树叶与黄瓜采用鲜品进行蒸馏水提取,在提取过程中加入二氧化硅有利于原料的充分捣碎,破坏原料中的团聚的成分,提高在焖煮过程中原料中的有效物质的溶出和扩散。而且,本发明人意料不到的发现小腊树叶与黄瓜一起提取时最终制备所得的消毒液的抑菌效果更好。可能的原因是这两种原料在水提过程中相互促进,使有效物质溶出的充分溶出。
在一种优选的实施方式中,第(2)步骤中小腊树叶和黄瓜的提取过程包括如下步骤:取所需重量的一半的小腊树叶和黄瓜切碎后加入二氧化硅,捣碎,然后加入蒸馏水在80℃下焖煮,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B。
本发明中山楂和马齿觅一起在60wt%乙醇水溶液中超声提取发现,其效果好,比单独提取后所的消毒液效果强。对体系进行超声,在超声空化作用在山楂和马齿觅的相互促进下,能使细胞壁破裂从而有助于内容物的浸出,增加了溶剂向细胞内的扩散和有效成分的溶出,从而大大缩短了提取时间,提高提取效率,且对被提取物质不产生破坏作用。而且在提取过程中加入聚乙二醇等分散剂时可以缩短提取时间,有利于一些易于团聚、难溶解等成分的溶出与扩散。
本发明中的超声提取是利用超声波对原料进行提取。超声波是一种弹性机械振动,它产生强烈的振动、高速度,以及强烈的空化效应,搅拌作用,因此超声波提取以超声波辐射压强产生的骚动效应、空化效应和热效应,引起机械搅拌,破坏山楂和马齿觅原料中的细胞,提高原料中有效成分的提取效果。
在一种优选的实施方式中,第(5)步骤中所述的分散剂选自十四烷基苯磺酸钠、聚乙二醇、十二烷基苯磺酸钠、硫酸铵中的一种或多种。
本发明中先对白芷进行蒸馏水提取,得到一些棕榈酸、豆甾醇、β-谷甾醇、β-胡萝卜素等有效水溶性成分。申请人意料不到的发现,将白芷水提后剩余的成分与蒲公英、小腊树叶一起,用乙酸乙酯提取时可以提高所得的消毒液对伤口的愈合能力。可能的原因是,提取过程中白芷中香柑内酯、欧前胡骨酯、珊瑚菜素、8-甲氧基-4-氧-(3-甲基-2-丁烯基)补骨脂素、栓翅芹烯醇等香豆素类化合物,以及正式二醇等挥发性油、胡萝卜苷、生物碱等成分,或者其它可能的活性成分的溶出率,使伤口消毒液能够破宿血,补新血,排脓生肌、活血止痛,提高消毒液的各项性能。此外,蒲公英、小腊树叶与白芷一起提取也可以促进蒲公英皂苷类、黄酮类、以及肌醇类等有效成分的溶出,而这些成分可以在一定程度上可以促进体内胰岛素的分泌作用,抵抗高血糖,甚至可以对由于糖尿病等而造成的伤口进行消毒,提高伤口消毒液的综合性能。
下面通过实施例对本发明进行具体描述。有必要在此指出的是,以下实施例只用于对本发明作进一步说明,不能理解为对本发明保护范围的限制,该领域的专业技术人员根据上述本发明的内容做出的一些非本质的改进和调整,仍属于本发明的保护范围。
实施例
实施例1
实施例1提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木20、黄瓜20、红花26、黄岑18、新疆紫草23、白芷25、马齿苋20、泽兰22、紫花苜蓿24、山楂25、黄柏26、大黄25、蒲公英24、金银花26、小腊树叶26、当归21。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和0.5wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值至4,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
实施例2
实施例2提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木32、黄瓜35、红花39、黄岑30、新疆紫草35、白芷35、马齿苋41、泽兰38、紫花苜蓿28、山楂45、黄柏42、大黄35、蒲公英37、金银花42、小腊树叶35、当归32。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和0.5wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、3wt%的无水硫酸镁和4倍重量的85wt%乙醇水溶液,调节pH值至4,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
实施例3
实施例3提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木20、黄瓜25、红花27、黄岑18、新疆紫草23、白芷25、马齿苋22、泽兰22、紫花苜蓿24、山楂25、黄柏26、大黄25、蒲公英24、金银花26、小腊树叶26、当归21。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和0.5wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值至6,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
实施例4
实施例4提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木26、黄瓜30、红花31、黄岑24、新疆紫草38、白芷30、马齿苋28、泽兰27、紫花苜蓿28、山楂32、黄柏34、大黄30、蒲公英31、金银花30、小腊树叶33、当归27。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和2.5wt%硫酸铵搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1wt%的无水硫酸镁和4倍重量的85wt%乙醇水溶液,调节pH值至4,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
实施例5
实施例5提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木20、黄瓜27、红花30、黄岑21、新疆紫草24、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和1.2wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1.5wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值至4.5,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
实施例6
实施例6提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木20、黄瓜27、红花30、黄岑21、新疆紫草24、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入4倍重量的蒸馏水,加热回流2小时,趁热过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液和第(3)步骤中所述新疆紫草滤渣粉末,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和1.2wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(6)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1.5wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值至4.5,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
对比例1
对比例1提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料包括苏木20、黄瓜27、红花30、黄岑21、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25。
所述温和型伤口消毒液的制备方法包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后按照1g粉料:15ml溶剂的比例加入50wt%乙醇水溶液,并加热回流1.5小时,过滤,滤渣中再加入50wt%乙醇水溶液加热回流1小时,过滤,两次过滤所得滤液合并,蒸发浓缩得到粘稠物A;
(2)取所需重量的一半的小腊树叶和所需量的黄瓜切碎后加入二氧化硅,捣碎,然后并加入4倍重量的蒸馏水,在80℃下焖煮2小时,过滤;滤渣中再加入蒸馏水在80℃下焖煮,过滤,两次过滤所得滤液合并,蒸发浓缩,得到粘稠物B;
(3)取所需重量的黄岑、大黄,烘干粉碎,然后加入15倍重量的75wt%乙醇水溶液,搅拌混合以650w的功率微波提取30min,过滤,将滤液浓缩得到D;
(4)取所需重量的山楂和马齿觅烘干粉碎后加入25倍重量的60wt%乙醇水溶液和1.2wt%十二烷基苯磺酸钠搅拌混合,然后在250w功率下超声提取45min,过滤,将滤液浓缩得到E;
(5)取所需重量一半的苏木烘干粉碎后加入粉末3倍重量的石油醚,加热回流2小时,趁热过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1.5wt%的无水硫酸钠和4倍重量的85wt%乙醇水溶液,调节pH值至4.5,加热回流,趁热过滤,滤液浓缩得到F;
(6)取所需重量的白芷,烘干粉碎,加入粉末5倍重量的蒸馏水,加热回流2小时,趁热过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和和白芷8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G;
(7)将上述第(1)~(6)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释,进行无菌处理后,得到所述的温和型伤口消毒液。
对比例2
对比例2提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(1)步骤中所述的苏木、红花、金银花、当归和泽兰按照第(1)所述的过程单独提取,分别得到A1,A2A3A4A5,这5个组分共混组成A。
对比例3
对比例3提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(2)步骤中所述小腊树叶和黄瓜按照第(2)步骤所述的过程单独提取之后共混得到粘稠物B。
对比例4
对比例4提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,制备过程中没有第(3)步骤,第(4)步骤中的所述新疆紫草滤渣粉末由所需量的新疆紫草代替,即伤口消毒液制备过程中没有对新疆紫草进行蒸馏水提取,而是直接和黄岑、大黄一起乙醇提取。当然,最后一步骤中也没有C。
对比例5
对比例5提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(4)步骤中所述黄岑、大黄,和第(3)步骤中所述新疆紫草滤渣粉末按照第(4)步骤的条件单独提取,得到D1,D2,D3这三个组分共混组成D。
对比例6
对比例6提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(5)步骤中没有加入分散剂。
对比例7
对比例7提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(5)步骤中所述山楂和马齿觅按照第(5)步骤所述的条件单独提取,得到E1,E2,由这两个组分共混组成E。
对比例8
对比例8提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(6)步骤紫花苜蓿和黄柏提取过程中不加入无水硫酸钠。
对比例9
对比例9提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(6)步骤中紫花苜蓿和黄柏按照第(6)步骤所述的过程单独提取得到F1,F2,由F1,F2和苏木提取粉末共混组成F。
对比例10
对比例10提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(6)步骤中紫花苜蓿和黄柏一起提取(只是两者一起提取,这两者没有跟苏木提取粉末一起提取),所得提取物与苏木提取粉末共混组成F。
对比例11
对比例11提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(7)步骤中没有对白芷进行蒸馏水提取,即没有H组分;G组分由所需量的蒲公英、所需重量一半的小腊树叶和所需量白芷按照第(7)步骤所述的过程提取得到。
对比例12
对比例12提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(7)步骤中所需量的蒲公英、所需重量一半的小腊树叶在蒲公英8倍重量的乙酸乙酯后加热回流1小时,离心沉淀过滤,滤液浓缩得到G1;白芷水提取后的滤渣粉末按照一样的方法提取得到G2,G1和G2共混组成G。
对比例13
对比例13提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(7)步骤中白芷水提取后的滤渣粉末与所需量的蒲公英按照(7)步骤所述的过程提取得到,而所需重量一半的小腊树叶单独按照(7)步骤所述的过程提取得到,两者共混组成G。
对比例14
对比例14提供了一种温和型伤口消毒液,所述温和型伤口消毒液的制备原料与实施例6所述的相同。
所述温和型伤口消毒液的制备方法与实施例6不同之处在于,第(7)步骤中白芷水提取后的滤渣粉、所需重量一半的小腊树叶和所需重量的蒲公英按照(7)步骤所述的过程单独提取得到后再共混组成G。
性能评价
1.抑菌性能测试
取金黄色葡萄球菌、大肠杆菌、白色念珠菌、绿脓杆菌的斜面培养物一环分别接种于肉汤培养基中,37℃培养24小时后,各取0.2毫升接种于3个平板培养基中,分别取等量的上述实施例和对比例中制备得到的温和型伤口消毒液分别滴于3个平板培养基中;作用3min后检测平均灭菌率,其余操作均符合《消毒技术规范》。
表1抑菌性能测试表
白色念珠菌 | 绿脓杆菌 | 金黄色葡萄球菌 | 大肠杆菌 | |
实施例1 | 88.4 | 90.1 | 89.4 | 89.2 |
实施例2 | 89.2 | 88.3 | 89.8 | 89.9 |
实施例3 | 89.0 | 88.4 | 88.6 | 89.1 |
实施例4 | 89.5 | 88.1 | 89.7 | 88.2 |
实施例5 | 89.7 | 89.4 | 90.2 | 90.6 |
实施例6 | 99.1 | 99.9 | 99.0 | 99.6 |
对比例1 | 80.1 | 76.0 | 75.2 | 77.4 |
对比例2 | 70.7 | 84.4 | 82.3 | 80.6 |
对比例3 | 80.2 | 78.4 | 79.1 | 78.8 |
对比例4 | 83.4 | 84.0 | 82.6 | 81.3 |
对比例5 | 80.1 | 81.4 | 79.5 | 79.7 |
对比例6 | 85.1 | 84.8 | 84.4 | 85.2 |
对比例7 | 82.0 | 81.5 | 81.2 | 82.3 |
对比例8 | 83.8 | 85.4 | 84.5 | 83.2 |
对比例9 | 79.6 | 80.4 | 79.4 | 80.0 |
对比例10 | 82.4 | 83.2 | 83.5 | 82.9 |
对比例11 | 81.0 | 78.4 | 81.2 | 81.7 |
对比例12 | 80.2 | 79.1 | 80.5 | 80.3 |
对比例13 | 81.3 | 80.1 | 79.7 | 79.4 |
对比例14 | 80.2 | 78.8 | 79.2 | 78.7 |
由表1可以看出本发明提供的温和型伤口消毒液对上述金黄色葡萄球菌、大肠杆菌、白色念珠菌、绿脓杆菌等易于感染伤口的细菌有很好的抑菌、杀菌效果,可以避免伤口的感染。
2.伤口愈合实验
随机选取健康,体重相当的实验用老鼠24只,对实施例5、实施例6、对比例2、对比例3、对比例5、对比例9和对比例14所提供的消毒液进行伤口愈合实验。对选取的老鼠腹部同样的位置切取直径约0.5cm的皮肤,并且用医用消毒液清洗伤口,等到滤纸吸不出伤口的血,伤口不再出血时,用相同浓度的本发明提供的伤口消毒液对伤口进行涂抹,每日涂抹4次,空白对照不涂抹伤口消毒液。观察伤口直径愈合到约原来的一半所需要的时间,记录为伤口愈合时间。
表2伤口愈合性能测试表
伤口愈合时间 | |
实施例5 | 16~19天 |
实施例6 | 11~14天 |
对比例2 | 19~23天 |
对比例3 | 17~20天 |
对比例5 | 17~20天 |
对比例9 | 17~20天 |
对比例14 | 18~21天 |
空白对照 | 超过27天 |
在整个伤口愈合实验过程中伤口消毒液对伤口的作用温和,由上表2可以看出,本发明提供的温和型伤口消毒液对伤口有明显的促进愈合作用,明显缩短伤口的愈合时间。
前述的实例仅是说明性的,用于解释本发明所述方法的一些特征。所附的权利要求旨在要求可以设想的尽可能广的范围,且本文所呈现的实施例仅是根据所有可能的实施例的组合的选择的实施方式的说明。因此,申请人的用意是所附的权利要求不被说明本发明的特征的示例的选择限制。在权利要求中所用的一些数值范围也包括了在其之内的子范围,这些范围中的变化也应在可能的情况下解释为被所附的权利要求覆盖。
Claims (6)
1.一种温和型伤口消毒液,其特征在于,所述温和型伤口消毒液的制备原料由苏木、黄瓜、红花、黄芩、新疆紫草、白芷、马齿苋、泽兰、紫花苜蓿、山楂、黄柏、大黄、蒲公英、金银花、小腊树叶、当归组成;
所述温和型伤口消毒液的制备原料,以重量份计,由苏木20~32、黄瓜20~35、红花26~39、黄芩18~30、新疆紫草23~35、白芷25~35、马齿苋20~41、泽兰22~38、紫花苜蓿24~28、山楂25~45、黄柏26~42、大黄25~35、蒲公英24~37、金银花26~42、小腊树叶26~35、当归21~32组成;
所述的温和型伤口消毒液的制备方法,至少包括如下步骤:
(1)取所需重量一半的苏木和所需量的红花、金银花、当归、泽兰烘干、粉碎后加入50wt%乙醇水溶液加热回流,过滤,浓缩滤液得到粘稠物A;
(2)提取所需重量的一半的小腊树叶和所需重量的黄瓜后过滤,滤液浓缩,得到粘稠物B;
(3)取所需重量的新疆紫草烘干粉碎后,加入蒸馏水加热回流,过滤,将滤液浓缩得到C;将滤渣烘干,得到新疆紫草滤渣粉末;
(4)取所需重量的黄芩、大黄,烘干粉碎,然后加入75wt%乙醇水溶液,搅拌混合微波提取,过滤,将滤液浓缩得到D;
(5)取所需重量的山楂和马齿苋烘干粉碎后加入60wt%乙醇水溶液和0.5~2.5wt%分散剂搅拌混合,然后在250w功率下超声提取,过滤,浓缩滤液得到E;
(6)取所需重量一半的苏木烘干粉碎后加入石油醚,加热回流,过滤,并将滤液浓缩烘干得到苏木提取粉末;取所需重量的紫花苜蓿和黄柏烘干粉碎后加入所述的苏木提取粉末、1~3wt%的助剂和85wt%乙醇水溶液,调节pH值,加热回流,趁热过滤,滤液浓缩得到F;
(7)取所需重量的白芷,加入蒸馏水,加热回流,过滤,滤液浓缩得到H;将滤渣烘干,并在烘干所得的粉末中加入所需量的蒲公英、所需重量一半的小腊树叶和乙酸乙酯后加热回流,离心沉淀过滤,滤液浓缩得到G;
(8)将上述第(1)~(7)步骤中所得A,B,C,D,E,F,G,H共混后加入医用酒精和蒸馏水稀释后进行无菌处理,得到所述的温和型伤口消毒液;
第(4)步骤中在所述黄芩和大黄烘干后还要加入第(3)步骤中所述新疆紫草滤渣粉末,然后微波提取;
第(6)步骤中的pH值控制在4~6。
2.如权利要求1所述的温和型伤口消毒液,其特征在于,所述温和型伤口消毒液的制备原料,以重量份计,由苏木20~26、黄瓜25~30、红花27~31、黄芩18~24、新疆紫草23~35、白芷25~30、马齿苋22~28、泽兰22~27、紫花苜蓿24~28、山楂25~32、黄柏26~34、大黄25~30、蒲公英24~31、金银花26~30、小腊树叶26~33、当归21~27组成。
3.如权利要求2所述的温和型伤口消毒液,其特征在于,所述温和型伤口消毒液的制备原料,以重量份计,由苏木20、黄瓜27、红花30、黄芩21、新疆紫草24、白芷26、马齿苋25、泽兰24、紫花苜蓿26、山楂28、黄柏31、大黄27、蒲公英24、金银花27、小腊树叶28、当归25组成。
4.如权利要求1所述的温和型伤口消毒液,其特征在于,第(6)步骤中所述助剂为无水硫酸钠和/或无水硫酸镁。
5.如权利要求1所述的温和型伤口消毒液,其特征在于,第(2)步骤中小腊树叶和黄瓜的提取过程包括如下步骤:取所需重量一半的小腊树叶和黄瓜切碎后加入二氧化硅,捣碎,然后加入蒸馏水在80℃下焖煮,过滤,浓缩滤液,得到粘稠物B。
6.如权利要求1所述的温和型伤口消毒液,其特征在于,第(5)步骤中所述的分散剂选自十四烷基苯磺酸钠、聚乙二醇、十二烷基苯磺酸钠、硫酸铵中的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810123942.7A CN108186775B (zh) | 2018-02-07 | 2018-02-07 | 一种温和型伤口消毒液及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810123942.7A CN108186775B (zh) | 2018-02-07 | 2018-02-07 | 一种温和型伤口消毒液及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108186775A CN108186775A (zh) | 2018-06-22 |
CN108186775B true CN108186775B (zh) | 2020-12-29 |
Family
ID=62592585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810123942.7A Active CN108186775B (zh) | 2018-02-07 | 2018-02-07 | 一种温和型伤口消毒液及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186775B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104138443A (zh) * | 2014-07-23 | 2014-11-12 | 董宝珍 | 一种治疗烧烫伤的外敷药酒 |
CN107519290A (zh) * | 2017-10-13 | 2017-12-29 | 张英 | 一种祛腐生肌膏及其制备方法 |
-
2018
- 2018-02-07 CN CN201810123942.7A patent/CN108186775B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104138443A (zh) * | 2014-07-23 | 2014-11-12 | 董宝珍 | 一种治疗烧烫伤的外敷药酒 |
CN107519290A (zh) * | 2017-10-13 | 2017-12-29 | 张英 | 一种祛腐生肌膏及其制备方法 |
Non-Patent Citations (2)
Title |
---|
Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats;Wei-Cheng Chen et al.;《Biomedcentral》;20121231;第1-9页 * |
小蜡树叶提取物的杀菌作用;梁增辉等;《军队卫生杂志》;19861231;第4卷(第1期);第28-31页,尤其是第28页正文第4-6行,第31页正文倒数第5-7行 * |
Also Published As
Publication number | Publication date |
---|---|
CN108186775A (zh) | 2018-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8632828B2 (en) | Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof | |
CN108392591B (zh) | 一种可预防阴道炎的纳米银女士抑菌平衡凝胶 | |
JPH01172341A (ja) | 家畜及び家禽のクロストリジウムパーフリンゲンス感染症の予防及び治療剤 | |
CN108785200B (zh) | 一种抗菌、祛痘、抗皱的银离子保湿面膜液、面膜及其制备方法 | |
Yan et al. | Vitex rotundifolia L. f. and Vitex trifolia L.: A review on their traditional medicine, phytochemistry, pharmacology | |
Dai et al. | Honey in traditional Chinese medicine: A guide to future applications of NADES to medicines | |
CN105396120B (zh) | 一种治疗痘坑及凹陷性疤痕的药物 | |
CN111870568A (zh) | 一种抗敏止痒植物组合物及其制备方法与用途 | |
CN110693997A (zh) | 一种烫伤烧伤祛腐生肌制剂及制备方法 | |
CN105982970B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
JP4869482B2 (ja) | 美白化粧料 | |
CN107233599B (zh) | 可快速去除空气内金属污染物的空气净化剂 | |
CN101361911A (zh) | 一种具有祛皱等功效皮肤外用组合物及其制法 | |
CN103655667A (zh) | 一种微波促进提取金银花中活性成分的方法 | |
CN108186775B (zh) | 一种温和型伤口消毒液及其制备工艺 | |
CN102206918B (zh) | 多用途中草药型熨衣液及其制备方法 | |
CN107308048A (zh) | 一种高效、长效且无副作用的祛痘霜 | |
CN111053937A (zh) | 一种植物萃取家用除臭除异味消毒组合物及其制备方法 | |
CN et al. | Antipyretic activity of aqueous extract of heart wood of Pterocarpus santalinus L. in yeast induced pyrexia | |
CN108096356B (zh) | 一种温和型伤口消毒液及其应用 | |
CN105288096B (zh) | 一种治疗青春痘的药物 | |
CN104958558B (zh) | 一种治疗烧伤的药物 | |
CN105999166A (zh) | 一种治疗冻疮的中药方剂及其制作方法 | |
KR101931952B1 (ko) | 천연추출물을 이용한 항노화화장료 조성물 및 이를 포함하는 항노화 화장품 | |
CN105213871A (zh) | 一种急诊科用杀菌止血中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |